A detailed history of Creative Planning transactions in Liquidia Corp stock. As of the latest transaction made, Creative Planning holds 145 shares of LQDA stock, worth $2,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145
Previous 17,023 99.15%
Holding current value
$2,335
Previous $170,000 99.41%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$9.82 - $11.8 $165,741 - $199,160
-16,878 Reduced 99.15%
145 $1,000
Q3 2024

Oct 11, 2024

BUY
$8.9 - $14.11 $151,504 - $240,194
17,023 New
17,023 $170,000
Q3 2023

Nov 16, 2023

BUY
$6.27 - $8.15 $2,194 - $2,852
350 New
350 $2,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.04B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.